Enzon Pharmaceuticals Inc (NASDAQ:ENZN)

1.29
Delayed Data
As of Apr 17
 -0.02 / -1.53%
Today’s Change
0.75
Today|||52-Week Range
1.66
+30.43%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2013
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Revenue and IncomeNet Revenues7.4M9.0M7.8M8.2M
 
 
 
 
 
Depreciation And Amortization14.0K0.000.00--
 
 
 
Operating ExpensesGross Income7.4M------
 
 
General Expenses1.4M508.0K836.0K571.0K
 
 
 
 
 
Research And Development190.0K0.00--0.00
 
 
Total Operating Expenses1.4M508.0K836.0K571.0K
 
 
 
 
 
 
Non-Operating ExpensesOperating Income6.0M8.5M6.9M7.6M
 
 
 
 
 
Extraordinary Charge-1.0M0.00----
 
 
Other Expenses792.0K109.0K-48.0K0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income5.5M8.6M6.9M7.6M
 
 
 
 
 
Income Taxes0.00-55.0K0.00-1.0K
 
 
 
Net Income5.5M8.5M6.9M7.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS43.8M44.1M44.1M44.1M
 
 
 
 
 
Shares To Calculate EPS Diluted51.0M44.3M44.3M44.2M
 
 
 
 
 
 
Earnings Per ShareEPS$0.12$0.19$0.16$0.17
 
 
 
 
 
EPS Diluted$0.09$0.19$0.16$0.17
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account